China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Hypofractionated Radiotherapy Plus Immunotherapy Versus Conventional Radiotherapy in Locally Recurrent Rectal Cancer'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600136292
Registration Time: 2026/11/09
Type: Interventional study
Primary Sponsor: Fudan University Shanghai Cancer Center
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338359
Published by HT Digital Content Services with permission from Health Daily Digest....